Gladstone Institutional Advisory’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.4M | Buy |
52,767
+3,523
| +7% | +$821K | 0.42% | 54 |
|
|
2026
Q1 | $12M | Sell |
49,244
-917
| -2% | -$214K | 0.45% | 49 |
|
|
2025
Q4 | $10.4M | Sell |
50,161
-2,470
| -5% | -$488K | 0.39% | 53 |
|
|
2025
Q3 | $9.76M | Sell |
52,631
-1,483
| -3% | -$254K | 0.38% | 55 |
|
|
2025
Q2 | $8.27M | Buy |
54,114
+393
| +0.7% | +$60.4K | 0.34% | 60 |
|
|
2025
Q1 | $8.91M | Buy |
53,721
+6,184
| +13% | +$968K | 0.42% | 52 |
|
|
2024
Q4 | $6.87M | Sell |
47,537
-5,414
| -10% | -$839K | 0.32% | 75 |
|
|
2024
Q3 | $8.58M | Sell |
52,951
-565
| -1% | -$90K | 0.42% | 58 |
|
|
2024
Q2 | $7.82M | Buy |
53,516
+1,551
| +3% | +$231K | 0.41% | 58 |
|
|
2024
Q1 | $8.22M | Buy |
51,965
+6,267
| +14% | +$998K | 0.45% | 46 |
|
|
2023
Q4 | $7.16M | Sell |
45,698
-723
| -2% | -$111K | 0.4% | 59 |
|
|
2023
Q3 | $7.23M | Sell |
46,421
-5,677
| -11% | -$937K | 0.47% | 48 |
|
|
2023
Q2 | $8.62M | Sell |
52,098
-31,896
| -38% | -$5.15M | 0.53% | 37 |
|
|
2023
Q1 | $13M | Buy |
83,994
+21,698
| +35% | +$3.5M | 0.84% | 18 |
|
|
2022
Q4 | $11M | Sell |
62,296
-717
| -1% | -$124K | 0.78% | 18 |
|
|
2022
Q3 | $10.3M | Buy |
63,013
+2,577
| +4% | +$436K | 0.8% | 22 |
|
|
2022
Q2 | $10.7M | Buy |
60,436
+3,901
| +7% | +$695K | 0.85% | 19 |
|
|
2022
Q1 | $10M | Buy |
56,535
+7,586
| +15% | +$1.29M | 0.68% | 26 |
|
|
2021
Q4 | $8.37M | Buy |
48,949
+9,488
| +24% | +$1.55M | 0.65% | 32 |
|
|
2021
Q3 | $6.37M | Buy |
39,461
+9,558
| +32% | +$1.63M | 0.62% | 38 |
|
|
2021
Q2 | $4.93M | Buy |
29,903
+15,426
| +107% | +$2.55M | 0.59% | 39 |
|
|
2021
Q1 | $2.38M | Buy |
14,477
+3,828
| +36% | +$619K | 0.37% | 68 |
|
|
2020
Q4 | $1.68M | Buy |
10,649
+2,494
| +31% | +$368K | 0.33% | 70 |
|
|
2020
Q3 | $1.21M | Buy |
8,155
+176
| +2% | +$26K | 0.29% | 77 |
|
|
2020
Q2 | $1.12M | Sell |
7,979
-2,600
| -25% | -$379K | 0.29% | 77 |
|
|
2020
Q1 | $1.39M | Buy |
10,579
+2,625
| +33% | +$372K | 0.36% | 64 |
|
|
2019
Q4 | $1.16M | Sell |
7,954
-90
| -1% | -$12.2K | 0.28% | 73 |
|
|
2019
Q3 | $1.04M | Buy |
8,044
+1,707
| +27% | +$225K | 0.26% | 76 |
|
|
2019
Q2 | $883K | Buy |
6,337
+3,215
| +103% | +$445K | 0.27% | 82 |
|
|
2019
Q1 | $437K | Sell |
3,122
-569
| -15% | -$76.2K | 0.16% | 119 |
|
|
2018
Q4 | $476K | Buy |
+3,691
| New | +$515K | 0.28% | 84 |
|
Other funds holding JNJ
Gladstone Institutional Advisory's JNJ Position: Q2 2026 in Review
Gladstone Institutional Advisory increased its Johnson & Johnson (JNJ) stake by 7.2% in Q2 2026, buying an estimated $821K and bringing the position to 52,767 shares worth $13.4M. The position accounts for 0.42% of the portfolio, ranked #54.
Gladstone Institutional Advisory first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Gladstone Institutional Advisory held 52,767 shares of Johnson & Johnson worth $13.4M as of Q2 2026.
- Gladstone Institutional Advisory bought 3,523 Johnson & Johnson shares in Q2 2026, an estimated $821K.
- Johnson & Johnson made up 0.42% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #54 holding.
- Gladstone Institutional Advisory first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
- 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.